CD8A and neoplasm: After GW3965 treatment, simultaneous blocking of CD19 and CD8 significantly increased tumour formation compared with the control-treated mice (Fig. 4f,g), demonstrating that B and T lymphocytes contribute to the LXR-mediated anti-tumour response.